• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Novartis Partners with SHYFT


Pharmaceutical Executive

SHYFT Analytics announced that Novartis selected its Intelligent Platform for Life Sciences to support the commercialization of therapies in Europe.

Novartis will use the following SHYFT solutions:

  • STRATA Data Platform to aggregate and manage a growing number of third party and proprietary commercial data sources

  • LUMEN Insights Platform to deliver intuitively-designed analytics to drive the “next-best-actions” for commercial teams


Related Videos
Related Content